Clinical Trial

Effect Of Nigella Sativa Oil for the Treatment of Hypertension

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
My research explores the antihypertensive effects of Nigella sativa (black seed) oil in managing high blood pressure. Hypertension is a growing global health concern, often insufficiently controlled by standard medications. Nigella sativa, known for its bioactive compound thymoquinone, possesses antioxidant, anti-inflammatory, and vasodilatory properties, making it a potential natural remedy for blood pressure regulation.
Trial Details
NCT Number NCT07055763
Lead Sponsor Superior University
Conditions Hypertension
Enrollment 60 participants
Start Date 2022-03-17
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-07-09